Pluristem Therapeutics Inc (PSTI)

[FDApproved]

MOVE OVER RIGHT-TO-TRY: FDA LOOKS AT IMPROVING CLINICAL TRIAL ENROLLMENT — Not everyone in Washington has been enthusiastic about letting very sick patients skirt FDA’s compassionate use program and request access to experimental medicines directly from drug companies. But there's widespread agreement that the clinical trials process needs tweaking to ensure patient access to unapproved drugs. Ways to improve participation include more inclusive enrollment criteria, new types of trial designs or using data from the agency's expanded access (compassionate use) program.



https://www.politico.com/tipsheets/prescription-pulse